MPG.eBooks - Search Results

1

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

2

CADTH Canadian Drug Expert Committee recommendation: Tofacinitib (Xeljanz)...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that tofacitinib be reimbursed...”

Read Now

3

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

4

CADTH Canadian Drug Expert Committee recommendation: Risankizumab (Skyrizi -- Abbvie) : indication : adult patients with moderate to severe plaque psoriasis

Published 2019

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that risankizumab be reimbursed...”

Read Now

5

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that migalastat be reimbursed...”

Read Now

6

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

Read Now

7

CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee recommends that cladribine be reimbursed as monotherapy...”

Read Now

8

CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.)...

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that rivaroxaban be reimbursed...”

Read Now

9

CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie)...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that upadacitinib be reimbursed for use...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

Read Now

11

CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.)...

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that guselkumab be reimbursed for adult...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.)...

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that rivaroxaban be reimbursed...”

Read Now

13

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that preservative-free latanoprost 50 μg...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that migalastat be reimbursed...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Esketamine (Spravato -- Janssen inc.)...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that esketamine not be reimbursed...”

Read Now

16

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that preservative-free latanoprost 50 μg...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.)...

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that guselkumab be reimbursed for adult...”

Read Now

18

CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie)...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that upadacitinib be reimbursed for use...”

Read Now

19

CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that buprenorphine extended-release...”

Read Now

20

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that ulipristal acetate be reimbursed...”

Narrow Search